CXCL10 and severe acute respiratory syndrome: In particular, early enhanced expression of interferon-inducible protein-10 (CXCL-10) and monocyte chemoattractant protein-1 (MCP-1) have been correlated with an adverse outcome during SARS-CoV infection in humans [38], [39], which was also highly upregulated in this study.